Victoria Vakiener, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 1,799 shares at $23.31 ($42K) on 2024-05-02, disclosed to the SEC on 2024-05-06.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2024-01-16 | $317K | — | Filing → |
| ARWR | SELL | 2023-10-02 | $41K | — | Filing → |
| EPZM | SELL | 2021-02-05 | $9K | — | Filing → |